| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 1.48M | — |
| Operating expense | — | — |
| Net income | -13.03M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, VTGN returned -92.2% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -62.7% |
| 1 year | -92.2% |
| 5 years | -99.7% |
| 10 years | -99.8% |
| All-time high | $1,830.00 (Dec 2011) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in VTGN would be worth today ›No. Vistagen Therapeutics, Inc. has not paid a dividend in the past 12 months.
Vistagen Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol VTGN.
Vistagen Therapeutics, Inc. is part of the Healthcare sector.
Vistagen Therapeutics, Inc. has a market cap of 10.92M USD, based on the latest quote.
Vistagen Therapeutics, Inc. is expected to report earnings around Nov 12, 2026. That date is an estimate and has not been confirmed by the company.
